Ulcers
18
1
1
13
Key Insights
Highlights
Success Rate
87% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
11.1%
2 terminated out of 18 trials
86.7%
+0.2% vs benchmark
22%
4 trials in Phase 3/4
46%
6 of 13 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 13 completed trials
Clinical Trials (18)
TrueLok Elevate PMCF Study
A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Venous Leg Ulcers
Effect of NIRS-assisted Assessment on Chronic Lower Extremity and Other Chronic Non-healing Ulcers
Study on the Effectiveness of Hypothermal Sulphurous Water in Wound Hygiene
Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-2)
Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-1)
Non-inferiority Clinic of Kollagenase® Compared Iruxol® in Treatment of Cutaneous Ulcers
SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic Wounds
Study of Hepatocyte Growth Factor (HGF) Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia Patients With Peripheral Ischemic Ulcers
Insulin Infusion Diabetes Ulcer
Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia
Cobiprostone Prevention of NSAID-induced Gastroduodenal Injury
Utility of Interface Pressure Mapping
Peripheral Vascular Disease and Nerve Stimulation
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Open Multi-centre Investigation to Evaluate Signs and Symptoms of Local Inflammation/Infection on Chronic Ulcers and Partial Thickness Burns When Using Mepilex Border Ag as an Anti-microbial Wound Dressing
Study Comparing a Fixed-Dose Capsule of Esomeprazole 40mg and LDA 325mg With Free Combination
Clinical Application of Autologous Three-Cellular Cultured Skin Substitutes (CSS)